Clinical Trial Update: Effect of Mepolizumab in Severe Bilateral Nasal Polyps [Phase 3]

View source ↗

Summary

Phase 3 trial update on mepolizumab for severe bilateral nasal polyps; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasal Polyps

Drugs mentioned

• Mepolizumab (mepolizumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Nasal Polyps | Phase 3 | Status: COMPLETED | Results posted: 2020-12-17